Internal Medicine, Hematology & Oncology · Bay Shore, NY
NPI
1982677761
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
180 E Main St
Bay Shore, NY, 11706
Phone (631) 751-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
117,049 services
Medicare patients, 2024
1,001
Average age 74
Drug cost, 2024
$5.9M
1,535 prescriptions
Company payments, 2025
$16.78
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gerry Rubin was code J1439 (injection, ferric carboxymaltose, 1 mg), 38,250 times for 31 patients. In total Gerry Rubin billed 117,049 services in 195 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 38,250 | 31 | $0.87 | $33K |
| J1756 Injection, iron sucrose, 1 mg | Office | 18,200 | 42 | $0.17 | $3,094 |
| 88185 Surgical Pathology Examination | Office | 3,204 | 114 | $22.02 | $71K |
| 36415 Venipuncture Blood Collection | Office | 1,927 | 593 | $8.63 | $17K |
| 85025 Blood Count | Office | 1,900 | 575 | $7.56 | $14K |
| 80053 Clinical Chemistry | Office | 1,492 | 518 | $10.31 | $15K |
| J0897 Injection, denosumab, 1 mg | Office | 1,380 | 13 | $20.17 | $28K |
| 99214 Office E&M - Established | Office | 1,293 | 440 | $108.71 | $141K |
| 82728 Clinical Chemistry | Office | 1,173 | 441 | $13.33 | $16K |
| 83540 Clinical Chemistry | Office | 1,164 | 439 | $6.33 | $7,370 |
| 83550 Clinical Chemistry | Office | 1,164 | 438 | $8.54 | $9,945 |
| 83735 Clinical Chemistry | Office | 842 | 362 | $6.51 | $5,483 |
| 83615 Clinical Chemistry | Office | 837 | 363 | $5.88 | $4,921 |
| 84550 Clinical Chemistry | Office | 799 | 346 | $4.39 | $3,510 |
| 84100 Clinical Chemistry | Office | 775 | 350 | $4.60 | $3,564 |
By year: 2022 $1.8M for 164,042 services; 2023 $1.3M for 128,935 services; 2024 $1.3M for 117,049 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 3,204 | 114 | $22.02 | $71K |
| 36415 Venipuncture Blood Collection | 1,927 | 593 | $8.63 | $17K |
| 85025 Blood Count | 1,900 | 575 | $7.56 | $14K |
| 80053 Clinical Chemistry | 1,492 | 518 | $10.31 | $15K |
| 82728 Clinical Chemistry | 1,173 | 441 | $13.33 | $16K |
| 83540 Clinical Chemistry | 1,164 | 439 | $6.33 | $7,370 |
| 83550 Clinical Chemistry | 1,164 | 438 | $8.54 | $9,945 |
| 83735 Clinical Chemistry | 842 | 362 | $6.51 | $5,483 |
| 83615 Clinical Chemistry | 837 | 363 | $5.88 | $4,921 |
| 84550 Clinical Chemistry | 799 | 346 | $4.39 | $3,510 |
Medicare prescription drug claims, 2024
In 2024, the drug Gerry Rubin prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 193 prescriptions and refills. In total Gerry Rubin wrote 1,535 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 193 | 193 | 38 | $715K |
| Xgeva Denosumab | 72 | 72 | 12 | $217K |
| Procrit Epoetin Alfa | 69 | 71 | 16 | $232K |
| Warfarin Sodium Generic | 62 | 119 | Under 11 | $517 |
| Letrozole Generic | 57 | 109 | 15 | $1,061 |
| Xarelto Rivaroxaban | 42 | 68 | 12 | $37K |
| Eliquis Apixaban | 41 | 57 | 12 | $34K |
| Xtandi Enzalutamide | 39 | 39 | Under 11 | $527K |
| Prednisone Generic | 39 | 39 | Under 11 | $152 |
| Dexamethasone Generic | 38 | 49 | Under 11 | $610 |
| Acyclovir Generic | 34 | 34 | Under 11 | $219 |
| Alprazolam Generic | 33 | 33 | Under 11 | $185 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 32 | 41 | Under 11 | $147 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 31 | 31 | Under 11 | $534K |
| Pomalyst Pomalidomide | 30 | 30 | Under 11 | $667K |
Brand drugs: 849 claims; generic drugs: 686 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gerry Rubin $16.78 ($16.78 in general payments such as food, travel and fees) from 1 company. The largest payer was Novartis Pharmaceuticals Corporation with $16.78.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 1 | $16.78 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.